These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14472428)

  • 1. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.
    MELNICK JL; STINEBAUGH S
    Proc Soc Exp Biol Med; 1962 Apr; 109():965-8. PubMed ID: 14472428
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.
    Henry JL; Jaikaran ES; Davies JR; Tomlinson AJ; Mason PJ; Barnes JM; Beale AJ
    J Hyg (Lond); 1966 Mar; 64(1):105-20. PubMed ID: 5219018
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.
    SLONIM D; MARES I; DREVO M; STURMOVA H; SIMON J
    Bull World Health Organ; 1962; 26(3):331-9. PubMed ID: 13913913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)].
    JUST M; BUERGIN-WOLFF A
    Ann Paediatr; 1962; 199():245-9. PubMed ID: 14452877
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal exfoliative dermatitis following injection of triple antigen and Salk vaccine.
    IAMS AM
    Am J Dis Child; 1960 Aug; 100():282-5. PubMed ID: 14405795
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the problem of intestinal complications following Sabin's oral poliomyelitis vaccination].
    DIESFELD HJ
    Med Klin; 1962 Aug; 57():1421-2. PubMed ID: 13886287
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the absence in French vaccine of the vacuolating agent (SV40 virus)].
    LEPINE P; SAUTTER V
    Bull Acad Natl Med; 1962 Feb 6-13; 146():112-5. PubMed ID: 14464170
    [No Abstract]   [Full Text] [Related]  

  • 8. Reaction to poliomyelitis vaccine; case report.
    CLYDE WA
    Arch Pediatr (N Y); 1956 Aug; 73(8):278-9. PubMed ID: 13363564
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to pencillin in British poliomyelitis vaccine.
    FOWDEN A
    Br Med J; 1958 Oct; 2(5100):835. PubMed ID: 13572922
    [No Abstract]   [Full Text] [Related]  

  • 11. EXCRETION OF SV-40 VIRUS AFTER ORAL ADMINISTRATION OF CONTAMINATED POLIO VACCINE.
    HORVATH BL; FORNOSI F
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():271-5. PubMed ID: 14267557
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatal encephalitis after poliomyelitis vaccination].
    ZISCHINSKY H; PENDL O; KUNZ C; JELLINGER K
    Klin Wochenschr; 1961 Jun; 39():638-45. PubMed ID: 13788641
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurological complications of poliomyelitis vaccination].
    VIZIOLI R; DE ROMANIS F
    Riv Neurol; 1962; 32():200-6. PubMed ID: 13926335
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against poliomyelitis with live virus vaccines. 6. Changes in Sabin type II oral vaccine virus after human passage.
    DANE DS; DICK GW; BRIGGS M; NELSON R; McALISTER J; CONNOLLY JH; HAIRE M; McKEOWN F; FIELD CM
    Br Med J; 1961 Jul; 2(5247):259-65. PubMed ID: 13719566
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination against poliomyelitis with live virus vaccines. 8. Changes in Sabin type I oral vaccine virus after multiplication in the intestinal tract.
    DANE DS; DICK GW; BRIGGS M; NELSON R; McALISTER J; CONNOLLY JH; McKEOWN F; FIELD CM
    Br Med J; 1961 Jul; 2(5247):269-71. PubMed ID: 13719567
    [No Abstract]   [Full Text] [Related]  

  • 16. A precipitin test for acute poliomyelitis and for assessing antibody response to oral poliovaccine.
    SELZER G
    J Hyg (Lond); 1962 Mar; 60(1):69-78. PubMed ID: 13910539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Demonstrations of complications in poliomyelitis vaccination and of the differential diagnosis of flaccid paralysis].
    BAUMANN T
    Schweiz Med Wochenschr; 1960 Jun; 90():623-7. PubMed ID: 13797719
    [No Abstract]   [Full Text] [Related]  

  • 18. [ORAL POLIOMYELITIS VACCINATION AND POST-VACCINAL POLIOMYELITIS].
    GARCIA L; SILVA H
    Maroc Med; 1964 Dec; 43():949-55. PubMed ID: 14257762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exacerbation of atopic dermatitis by antipoliomyelitic vaccine].
    ASRILANT M; INGLESINI C; DE SCHNIR RE
    Sem Med; 1961 Nov; 119():1769-70. PubMed ID: 13862945
    [No Abstract]   [Full Text] [Related]  

  • 20. Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine.
    Reid D; Yetts R; Oddy CG; Benson PF
    Lancet; 1969 Mar; 1(7594):564-6. PubMed ID: 4179849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.